1. Home
  2. BYND vs EYPT Comparison

BYND vs EYPT Comparison

Compare BYND & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

HOLD

Current Price

$7.15

Market Cap

231.6M

ML Signal

HOLD

EYPT

EyePoint Pharmaceuticals Inc.

SELL

Current Price

$3.03

Market Cap

273.3M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
BYND
EYPT
Founded
2009
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
231.6M
273.3M
IPO Year
2018
2005

Fundamental Metrics

Financial Performance
Metric
BYND
EYPT
Price
$7.15
$3.03
Analyst Decision
Sell
Buy
Analyst Count
3
13
Target Price
$12.50
★ $25.91
AVG Volume (30 Days)
1.2M
★ 3.1M
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 24.69
N/A
EPS
★ N/A
N/A
Revenue
★ $275,496,000.00
$7,539,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$967.16
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.40
$3.05
52 Week High
$15.47
$19.11

Technical Indicators

Market Signals
Indicator
BYND
EYPT
Relative Strength Index (RSI) 31.91 30.21
Support Level $0.63 N/A
Resistance Level $12.52 $14.72
Average True Range (ATR) 0.39 0.21
MACD -0.23 0.15
Stochastic Oscillator 0.15 9.52

Price Performance

Historical Comparison
BYND
EYPT

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: